To give information about chemotherapy agents used as standard in cancer treatment and new treatment methods such as immunotherapy, biological, hormonal and targeted therapies.

The pharmacokinetics and pharmacodynamics of chemotherapy agents, alkylating agents, platinum analogues, antimetabolites, topoisomerase inhibitors, antimicrotubule agents, anti-Her2 agents, tyrosine kinase inhibitors, and their antiangiogenic agents in their individualized treatment will be described.